Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines
about
Systemic lupus erythematosusCatastrophic antiphospholipid syndrome: how to diagnose a rare but highly fatal diseaseCatastrophic antiphospholipid syndrome: a clinical reviewRituximab and its therapeutic potential in catastrophic antiphospolipid syndromeThe clinical significance of antiphospholipid antibodies in systemic lupus erythematosusInternational consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)Diagnosis and management of catastrophic antiphospholipid syndrome.Systematic review of case reports of antiphospholipid syndrome following infection.Successful Treatment of Catastrophic Antiphospholipid Antibody Syndrome Associated with MALT Lymphoma by Autologous Hematopoietic Stem Cell Transplantation.The systemic nature of the antiphospholipid syndrome.Thrombotic microangiopathy in adult Still's disease.Successful treatment of life-threatening Evans syndrome due to antiphospholipid antibody syndrome by rituximab-based regimen: a case with long-term follow-up.Clinical manifestations and outcomes of antithrombotic treatment of the Tan Tock Seng Hospital Singapore antiphospholipid syndrome cohort.Massive cerebrovascular infarct due to the catastrophic antiphospholipid syndrome in a patient with idiopathic thrombocytopenic purpura.Progression of antiphospholipid antibody syndrome to catastrophic antiphospholipid antibody syndrome acutely with cessation of antithrombotic therapy.Vascular endothelial cell function in catastrophic antiphospholipid syndrome: a case report and review of the literature.Outcomes of patients with antiphospholipid syndrome after pulmonary endarterectomy.Catastrophic antiphospholipid syndrome with severe acute thrombotic microangiopathy and hemorrhagic complications.Catastrophic APS in the context of other thrombotic microangiopathies.Management of the antiphospholipid syndromeA 3-year follow-up of a patient with acute renal failure caused by thrombotic microangiopathy related to antiphospholipid syndrome: case report.Fatal antiphospholipid syndrome following endoscopic transnasal-transsphenoidal surgery for a pituitary tumor: A case report.Simultaneous Occurrence of Deep Vein Thrombosis and Carotid Artery Thrombosis in Antiphospholipid Antibody SyndromeSEQUENTIAL CENTRAL RETINAL VEIN AND OPHTHALMIC ARTERY OCCLUSIONS IN A PEDIATRIC CASE OF PRIMARY ANTIPHOSPHOLIPID SYNDROMEAntiphospholipid antibodies in critically ill patients.Guidelines on the use of therapeutic apheresis in clinical practice--evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis.New therapeutic targets for the antiphospholipid syndrome.When You are About to Diagnose Chronic Hemolytic Uremic Syndrome, Please Think More Deep.Plasmapheresis in a patient with antiphospholipid syndrome before living-donor kidney transplantation: a case report.Catastrophic cerebral antiphospholipid syndrome presenting as cerebral infarction with haemorrhagic transformation after sudden withdrawal of warfarin in a patient with primary antiphospholipid syndrome.Treatment of the antiphospholipid syndrome.Extensive vascular occlusions as initial presentations of systemic lupus erythematosis. A case report and review of literatureAntiphospholipid syndrome associated with infections: clinical and microbiological characteristics of 100 patients.Validation of the preliminary criteria for the classification of catastrophic antiphospholipid syndrome.Catastrophic antiphospholipid syndrome (CAPS): A rare and fatal encounter.Single-step autoantibody profiling in antiphospholipid syndrome using a multi-line dot assay.Increased Performances of the Biological Diagnosis of the Antiphospholipid Syndrome by the Use of a Multiplex AssayThe acute respiratory distress syndrome in catastrophic antiphospholipid syndrome: analysis of a series of 47 patientsBemiparin versus low dose aspirin for management of recurrent early pregnancy losses due to antiphospholipd antibody syndromeAutonomic dysfunction and primary antiphospholipid syndrome: a frequent and frightening correlation?
P2860
Q24543555-07ADF258-E89E-46B4-A99A-5A2F58085649Q26825077-C3D4D950-DF51-47D4-A710-E0BB3C140C4BQ27009935-FC8B9E2D-5AEE-41B0-A03B-49FA9B6F85D7Q27021256-EE8FB7AE-2619-4CFD-8297-0FC0208184C9Q28072610-647988E5-816B-4966-9029-BF78CA82AAB2Q28292418-77163E1C-B612-437B-905C-82DEF1790816Q30235356-F118E353-57DE-4BFD-89FE-E03CC1FA2F16Q30243901-0AA0DE8C-E49C-4D52-B2A4-4490E49BF97AQ32182200-258D4B7A-0CF0-412D-905C-7983DDA5BD13Q33365607-50CB1F03-A020-43E4-9840-6E807AC37055Q33368977-A214A8C8-D1A1-4BC7-88BD-445808FE45CBQ33380344-61127874-A9A5-4069-8F6F-B49AAFFFF777Q33384874-7F63BD27-142D-4356-A135-38917CFC87FAQ33385438-A55B0619-27BF-4A76-9AE9-86B88BD2DC85Q33401365-AC3147C6-E31A-4A6A-96BF-7509BFADCFA5Q33408341-98A44D3C-179D-4F88-AAED-F8F46C1A86C8Q33412248-868A88C0-C3DF-492D-AF80-56A1A553D28BQ33412407-2DAB9AD8-BFA4-4CDD-A46C-8407936EF20FQ33419886-DBB5E81C-9A5F-45BE-AE60-22F820F15619Q33423034-3DE5F954-0586-4DE5-9A63-3AC1C58FA21DQ33437339-52ABF97F-1052-4513-8668-7176F4155888Q33438290-504B64E7-5ECC-428E-86C1-F2CB467E7B14Q33595036-B8121C82-9467-4612-B8C8-92B940BECA92Q33906941-448BBC33-56D6-4D84-B725-389D083719CCQ33921875-404CBB4D-9446-49BA-AB9C-A796872AAB9BQ34122035-888F5493-E3FB-4958-989A-0B1C0553BA78Q34140319-9E4BA4D3-FF3B-4C47-972B-012066EFD0E4Q34340560-5E9D6C3F-AAA3-4B73-B327-BBFBA82E2837Q34436283-958DD1FD-4C50-440D-BF4D-878A33A32927Q34526465-F1CC1DD0-F03D-4DAB-B5C5-8053073CF2FFQ35308972-02CB13B0-97C0-4028-AAFE-0D30975EA704Q35382247-9BD1370B-E227-4146-B23C-BC882E19108DQ35553410-1F26DEFC-B341-421B-9A9B-C4BA9F6E2365Q35555909-F8A256D6-7871-45B7-84DF-E50A9056607FQ35603756-652D2237-202F-43BA-96A4-88BB5A7FEC1EQ35617645-7974078A-ED1A-40B2-8FB2-C88F8869128BQ35625927-00095FB1-7EED-4B0F-B8F2-4AAACB510CBBQ35636571-0F3165A7-7DC6-4E91-8837-D6E83A8E0D20Q35751482-41CCE898-2285-43B1-A302-9A941DB3F98CQ35905997-06F9995A-2570-4AD8-94E7-2AE71335BC58
P2860
Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines
description
2003 nî lūn-bûn
@nan
2003 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Catastrophic antiphospholipid ...... teria and treatment guidelines
@ast
Catastrophic antiphospholipid ...... teria and treatment guidelines
@en
Catastrophic antiphospholipid ...... teria and treatment guidelines
@en-gb
type
label
Catastrophic antiphospholipid ...... teria and treatment guidelines
@ast
Catastrophic antiphospholipid ...... teria and treatment guidelines
@en
Catastrophic antiphospholipid ...... teria and treatment guidelines
@en-gb
prefLabel
Catastrophic antiphospholipid ...... teria and treatment guidelines
@ast
Catastrophic antiphospholipid ...... teria and treatment guidelines
@en
Catastrophic antiphospholipid ...... teria and treatment guidelines
@en-gb
P2093
P2860
P50
P3181
P1433
P1476
Catastrophic antiphospholipid ...... teria and treatment guidelines
@en
P2093
P2860
P304
P3181
P356
10.1191/0961203303LU394OA
P577
2003-07-01T00:00:00Z